About Subtle Medical
Subtle Medical is the world leader in applying deep learning to medical image acquisition, enabling faster, safer, and smarter medical imaging across MRI, PET, and CT modalities. Founded at Stanford University by Dr. Greg Zaharchuk, a neuroradiologist and professor, and Dr. Enhao Gong, a deep learning scientist, the company was born from their shared passion for improving the quality and access of medical imaging through artificial intelligence. With over $85 million raised and more than 75 full-time employees, Subtle Medical has deployed its solutions on over 1,300 scanners across multiple countries globally. The company's flagship products include the Subtle-ELITE™ suite for MRI (featuring SubtleHD™, SubtleSYNTH™, and SubtleALIGN™), SubtleHD™ for PET and CT imaging, and AiMIFY™ in partnership with Bracco. These vendor-neutral solutions work on existing scanners, old and new, dramatically improving image quality while reducing scan times and enabling more efficient patient care. Subtle Medical serves radiology practices, imaging centers, health systems, and hospitals worldwide, with customers including RadNet, Precision Imaging Centers, Capital Health, and Middlesex Health. The company holds 11 FDA clearances, has 30+ issued or pending patents, and has published 25+ peer-reviewed papers demonstrating clinical evidence and outcomes. Their mission is to empower physicians and patients with safe and timely medical imaging that leads to improved outcomes and a higher quality of life for all.
Mission & Story
Mission
Our vision is that every human being has the opportunity for a timely diagnosis, high-quality care, and a longer, healthier life. We exist to empower physicians and patients with safe and timely medical imaging that leads to improved outcomes and a higher quality of life for all.
Founding Story
Subtle Medical was born out of Stanford University by founders Greg Zaharchuk, MD, Ph.D., a Neuroradiologist and Professor at Stanford, and Enhao Gong, Ph.D., a deep learning scientist. Enhao was studying under Dr. Zaharchuk during his Ph.D. program, where they discovered their joint passion for improving the quality and access of medical imaging and recognized the power of deep learning to allow them to do so. This ignited the ambition to start Subtle Medical, and it was eventually accepted into the elite Stanford StartX program.
Clinical Focus
Medical conditions and clinical areas addressed by Subtle Medical.
Who It Serves
Milestones & Awards
Recent Milestones
Named to TIME World's Top HealthTech Companies 2025. Semi-finalist for Aunt Minnie's Best New Radiology Software 2025. Named to CB Insights Generative AI 50 (2023) and Digital Health 100 (2023). Deployed on over 1,300 scanners globally. Raised over $85 million in funding. Ohad Arazi joined as CEO in 2026.
Awards & Recognition
TIME World's Top HealthTech Companies 2025, CB Insights Generative AI 50 (2023), CB Insights Digital Health 100 (2023), CB Insights Digital Health 150 (2022), Aunt Minnie's Best New Radiology Software semi-finalist (2025, 2021), Forbes 30-under-30 (founder Enhao Gong)
Key Partnerships
Social & Media
Latest Updates
Subtle Medical Secures $33 Million in Growth Capital Led by Morgan Stanley Expansion Capital and Appoints Industry Veteran Ohad Arazi as CEO
Subtle Medical Enters UK Market to Drive Faster, Higher Quality MRI with SubtleHD(MR)™
Subtle Medical Receives FDA Clearance for SubtleHD™(CT), Expanding AI-Powered Image Enhancement into CT Imaging
Subtle Medical Advances the Future of AI-Powered Imaging at ECR 2026
Subtle Medical to Showcase AI Innovations at NVIDIA GTC 2026
Company Details
- Employees
- 51-200
Work here?
Claim this listing to update company information and connect with our audience.
Claim This ListingOfficial Sources
Similar Companies in this Market
View all 189 →A2z Radiology Ai
AI platform that triages urgent abdomen-pelvis CT findings and prioritizes flagged studies in radiology worklists.
Adas3D Medical S.L
11-50 employees
Adas3D Medical develops medical imaging software that extracts key clinical information from cardiac MRI and CT scans for electrophysiologists. The software helps plan, guide, and monitor catheter ablation procedures by visualizing and quantifying fibrotic tissue in the heart.
AEYE Health
11-50 employees
AEYE Health provides FDA-cleared autonomous AI diagnostic screening for diabetic retinopathy and other eye diseases using retinal images. Their point-of-care solution enables primary care physicians to screen and diagnose patients instantly with portable or desktop cameras.
Agfa HealthCare N.V.
AGFA HealthCare provides enterprise imaging platforms that unify medical imaging across specialties. The company delivers PACS, vendor neutral archives, AI-powered workflow orchestration, and cloud-based imaging solutions to hospitals and healthcare systems worldwide.
AI4MedImaging Medical Solutions
AI4MedImaging provides AI-powered medical imaging solutions distributed through aycan Medical Systems in the Americas. Their flagship product, AI4CMR, is software as a medical device (SaMD) that automates the interpretation of cardiac magnetic resonance imaging using artificial intelligence.
Aidence
Aidence, now part of DeepHealth, develops AI-powered clinical applications for radiology and medical imaging. The company specializes in lung nodule detection, classification, and patient management solutions that empower radiologists and physicians in interpreting medical images.
Aidoc
growth · 350 employees
Aidoc empowers health systems to improve patient outcomes and operations with enterprise-grade healthcare AI.
Aikenist Technologies Pvt Ltd
21-100 employees
Aikenist Technologies is a MedTech company specializing in advanced AI-driven solutions for radiology imaging. Their offerings include an FDA-approved AI PACS and RIS with integrated viewer, appointment scheduling, billing modules, and AI tools for stroke, oncology, and neuro detection.
Data Accuracy Notice: Company information on HealthAI Central is compiled from public sources and updated regularly. While we strive for accuracy, details such as funding figures, employee counts, and product offerings may change. We recommend verifying critical information directly with the company before making business decisions.